InvestSMART

ECS Botanics Holdings Ltd (ASX: ECS) - Announcements

- Current share price for ECS : $0.006

ASX company news and announcements for ECS Botanics Holdings Ltd (ECS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ECS Botanics Holdings Ltd (ECS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ECS Botanics Holdings Ltd (ECS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ECS Botanics Holdings Ltd (ECS)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$10 ECS FY25 Results 29 Aug 2025 11:58AM $0.008 $0.006 fallen by 20%
$10 Appendix 4G & Corporate Governance Statement 29 Aug 2025 11:55AM $0.008 $0.006 fallen by 20%
$10 Appendix 4E & Annual Report 29 Aug 2025 11:53AM $0.008 $0.006 fallen by 20%
$10 Appendix 4E & Annual Report 29 Aug 2025 11:53AM $0.008 $0.006 fallen by 20%
$10 Notification of cessation of securities - ECS 19 Aug 2025 8:06AM $0.008 $0.006 fallen by 25%
$10 Final Director's Interest Notice 19 Aug 2025 8:06AM $0.008 $0.006 fallen by 25%
$10 Resignation of Non Executive Director 19 Aug 2025 8:06AM $0.008 $0.006 fallen by 25%
$10 Q4 FY25 Investor Presentation 7 Aug 2025 11:00AM $0.009 $0.006 fallen by 29.41%
$10 Q4 FY25 Investor Webinar 30 Jul 2025 9:24AM $0.008 $0.006 fallen by 25%
$10 Quarterly Activities/Appendix 4C Cash Flow Report 28 Jul 2025 9:10AM $0.009 $0.006 fallen by 33.33%
$10 ECS to support UWA medicinal cannabis clinical trial 7 Jul 2025 9:21AM $0.010 $0.006 fallen by 40%
$10 Terphogz Launch 30 Jun 2025 8:49AM $0.009 $0.006 fallen by 33.33%
$10 Change of Director's Interest Notice 23 Jun 2025 8:22AM $0.009 $0.006 fallen by 33.33%
$10 Record Harvest and Expansion of Premium B2C Product Line 16 May 2025 9:53AM $0.009 $0.006 fallen by 33.33%
$10 Q3 FY25 Investor Presentation 29 Apr 2025 9:29AM $0.012 $0.006 fallen by 50%
$10 Quarterly Activities/Appendix 4C Cash Flow Report (amended) 28 Apr 2025 12:50PM $0.011 $0.006 fallen by 45.45%
$10 Quarterly Activities/Appendix 4C Cash Flow Report 28 Apr 2025 8:19AM $0.013 $0.006 fallen by 53.85%
$10 Q3 Webinar Invitation 24 Apr 2025 12:14PM $0.012 $0.006 fallen by 50%
$10 ECS Secures Additional Growth Funding 14 Apr 2025 8:24AM $0.011 $0.006 fallen by 45.45%
$10 ECS to present at NWR Virtual Healthcare Conference 18 Mar 2025 12:06PM $0.013 $0.006 fallen by 53.85%
$10 ECS Half Year FY25 Results 28 Feb 2025 8:05AM $0.014 $0.006 fallen by 57.14%
$10 Half Yearly Report and Accounts 28 Feb 2025 8:04AM $0.014 $0.006 fallen by 57.14%
$10 Quarterly Activities/Appendix 4C Cash Flow Report 28 Jan 2025 8:33AM $0.017 $0.006 fallen by 64.71%
$10 Change of Director's Interest Notice (X3) 16 Dec 2024 3:53PM $0.017 $0.006 fallen by 64.71%
$10 Cleansing Notice 16 Dec 2024 3:51PM $0.017 $0.006 fallen by 64.71%

51 - 75 of 413 results

Page 3 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.